Key points are not available for this paper at this time.
The primary objective of this investigation is to evaluate the clinical and radiographic findings of mineral trioxide aggregate (MTA) and Biodentine (BD) as pulpotomy agents in primary molars. Two hundred primary molars (N=200) were treated with pulpotomy. Clinical and radiographic outcomes, including both successes and failures, were documented throughout a 36-month follow-up period. Statistical analyses were performed using the Fisher Exact, McNemar, and Chi-Square tests. No statistically significant differences in success rates were found between the 1-, 3-, 6-, 24-, and 36-month assessments for each material when evaluated independently. However, at the twelfth month, the clinical and radiographic success rates for MTA (98% and 92%, respectively) were significantly higher than those for BD (90% and 80%, respectively) with a p-value of less than 0.05. In this study, MTA demonstrated greater success than BD at 36 months. Nevertheless, higher quality randomized controlled trials with longer follow-up periods are necessary to obtain more reliable results.
Koruyucu et al. (Thu,) studied this question.